Cypress Bioscience Prosorba Rheumatoid Arthritis Trial Gets HCFA Nod
This article was originally published in The Gray Sheet
Executive Summary
Unpublished information generated in Cypress Bioscience's Prosorba clinical trial for rheumatoid arthritis was instrumental in the Health Care Financing Administration's decision to cover treatment for the Medicare population.